Mutations or loss of TSC1/2 lead to hyperactivation of mTORC1 signaling and have been associated with many human disorders, such as lymphangioleiomyomatosis (LAM) and autism [94]. This evidence concerns the gene TSC1 and lymphangioleiomyomatosis.